2025 annual financial data
China SXT Pharmaceuticals 2025 Net margin
China SXT Pharmaceuticals 2025 net margin with verified reported values.
Direct answer
Net margin was -189.77%.
Operating income was -2,680,479 USD and net income was -3,303,652 USD.
Operating cash flow was -2,345,333 USD.
Get free China SXT Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,740,907 USD
- Operating income
- -2,680,479 USD
- Net income
- -3,303,652 USD
- Operating cash flow
- -2,345,333 USD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Operating cash flow marginView all China SXT Pharmaceuticals financial years